Amgen
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Amgen and other ETFs, options, and stocks.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA.
AMGN Key Statistics
AMGN News
Mirati Therapeutics (MRTX) said almost half of patients responded to its lung cancer regimen, but MRTX stock crashed Tuesday as investors questioned whether it...
A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen AMGN we detected 13 strange trades....
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi Johnson & Johnson dropped out of the bidding process for Horizon Therapeutics, pushin...
Analyst ratings
61%
of 23 ratingsAMGN Earnings
More AMGN News
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about......
LOS ANGELES, Dec 3 (Reuters) - Amgen Inc's (AMGN.O) experimental obesity drug demonstrated promising durability trends in an early trial, paving t...
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. And the truth is, you can...
Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year...
Amgen stock — which is already trading near a record high — could get a fresh boost Thursday after the company unveiled promising results for its obesity treatm...
The first detailed look at data on Amgen Inc.’s obesity drug offers a promising glimpse into the future of weight-loss treatment. How promising? Sure, it’s earl...
Tagari joins insitro from Amgen, where he led the discovery of multiple important new therapies across therapeutic areas and modalities for more than two decade...
